You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 13 No. 5, November 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Homocystinuria

H. H. WHITE, MD; L. P. ROWLAND, MD; S. ARAKI, MD; H. L. THOMPSON, PhD; D. COWEN, MD

Arch Neurol. 1965;13(5):455-470.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN NOVEMBER, 1962, a family with an unusual neurological disorder was encountered. When the urinary excretion of amino acids was studied in January 1963, a unique pattern was seen and we thought we were dealing with a new syndrome. It soon became apparent that the same disorder had been described by Carson and Neill,5 and Gerritsen et al11 during the preceding months. These authors, together with Cusworth, Dent, Field and Westall3,7 had identified the abnormal compound as homocystine. Since then about 20 cases have been discovered1,3,7,12,16,18,23 and the biochemical abnormality has been identified as a deficiency of cystathionine synthetase.23

The family to be described here illustrates the typical features of the disease. Biochemical and neuropathological studies were carried out in two of three affected individuals (cases 2 and 3), and some neuropathological data were available in the third (case 1). . . . [Full Text PDF of this Article]


Author Affiliations

KANSAS CITY, KAN; NEW YORK; EL PASO, TEXAS; NEW YORK

From the Neurology Service, William Beaumont General Hospital, El Paso, Tex; the departments of neurology and pathology (division of neuropathology) Columbia University; and the Neurological Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center, New York. Formerly Captain (MC) US Army, presently assistant professor of Medicine (neurology) University of Kansas (Dr. White); associate professor of neurology, Columbia University, (Dr. Rowland); formerly Fellow, National Multiple Sclerosis Society at Columbia University, presently associate professor of neurology, Kyushu University, Japan (Dr. Araki); Lt Col US Army (Dr. Thompson); professor of neuropathology, Columbia University (Dr. Cowen).


Footnotes

Submitted for publication May 25, 1965; accepted July 6.

Read in part before the 89th Annual Meeting of the American Neurological Association, June 1964.

Reprint requests to 710 W 168th St, New York, NY 10032 (Dr. Rowland).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.